SCHEMBL2201623

SCHEMBL2201623

Cn1nc(-c2cccc(-c3cc4ccccc4o3)c2)cc1C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.56
ALDH1A1 P00352 5/20 0.56
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
MAPT P10636 2/20 0.43
TSHR P16473 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
NPC1 O15118 1/20 0.43
NFKB1 P19838 1/20 0.43
NPY1R P25929 1/20 0.43
RAB9A P51151 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PHGDH O43175 5/20 0.42
ALOX5 P09917 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2202745 0.88 KDM4E (0.45) KDM4EALDH1A1MAOAMAOBMAPT
SCHEMBL2201625 0.83 KDM4E (0.58) KDM4EALDH1A1MAOAMAOBMAPT
SCHEMBL2199127 0.79 MAOB (0.45) KDM4EALDH1A1MAOAMAOBMAPT
SCHEMBL2792109 0.78 PHGDH (0.61) PHGDHPTPN1PIN1CA12CA1
SCHEMBL12429330 0.77 GRIN2B (0.44) KDM4EALDH1A1MAPTTSHRHSD17B10
SCHEMBL2199009 0.77 GRM5 (0.46) KDM4EALDH1A1MAOAMAOBMAPT
SCHEMBL2199991 0.76 HTR2A (0.43) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL4601674 0.76 MAOB (0.58) KDM4EALDH1A1MAOAMAOBMAPT
SCHEMBL10960444 0.74 KMO (0.51) KDM4EALDH1A1MAPTL3MBTL1NPC1
SCHEMBL8843320 0.73 PHGDH (0.47) KDM4EPHGDHPTPN1PIN1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977358-B2 Pyrazol derivatives HOFFMANN-LA ROCHE INC. (US) 2011-07-12 US disclosed
EP-2182953-A2 NEW PYRAZOL DERIVATIVES F. Hoffmann-Roche AG (CH) 2010-05-12 EP disclosed
US-20090029963-A1 PYRAZOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-01-29 US disclosed
WO-2009013211-A2 NEW PYRAZOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-01-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029963-A1 PYRAZOL DERIVATIVES CCR1, CCR3, CCRL2 KDM4E 3694/4885ALDH1A1 1476/4885MAOA 4691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.